Objective-To compare the mortality in babies refused admission to a regional perinatal centre with that in babies accepted for intensive care in the centre.
Introduction
Several studies have investigated outcome in babies of low birth weight after transfer either prenatally or postnatally to a regional neonatal intensive care unit and compared it with that in babies born outside the regional centres.`Although such comparisons seem to justify transfer, confounding variables must be taken into account in the statistical analysis.4 A working party of the Royal College of Physicians recently reported a national shortage of intensive care cots. As a result of this shortage obstetricians and paediatricians in district maternity units may be unable to secure the admission of all babies to intensive care units. It is therefore imperative to compare survival in babies after transfer with that in babies for whom transfer was requested but refused because of lack of facilities in the regional unit. To date there have been two such studies both restricted to transfer of babies postnatally, which suggested that mortality in infants who are refused transfer is higher than that in those who are transferred. We studied babies who were referred prenatally or postnatally and refused admission to a regional perinatal centre over three years.
Patients and methods
Northern Ireland is the size of a small regional health authority and has 25 maternity hospitals for 28000 births each year. to 1-9; p>005). For the babies who were refused intensive care and received only special care the relative odds on death were 3 5 (1-7 to 7 0), indicating a significantly higher mortality (p<0-001) (fig 1) . A subgroup analysis was performed on babies who weighed less than 1500 g and who were born at -32 weeks' gestation. Relative to babies admitted to the centre the odds on death were similar for babies refused admission but admitted to other, smaller neonatal intensive care units (1-0; 0 5 to 2 1). In the babies who were refused intensive care and received only special care, the relative odds on death were significantly higher (8 4; 2 5 to 28 1).
Discussion
Only two previous studies (both from the same hospital) have compared the outcome in babies refused admission with those accepted for neonatal intensive care.67 These studies concluded that the babies refused admission had a poorer outcome, but each study had drawbacks in design. The first study considered only BMJ VOLUME 299 9 SEPTEMBER 1989one year of referrals and hence the numbers were small.' The second study covered three years and included larger numbers of babies, but only referrals made postnatally were considered. In both studies no account was taken of confounding variables that could influence neonatal mortality.
Our study of referrals to the regional perinatal centre included hospitals from all over Northern Ireland. Cross regional referrals are not made in Northern Ireland and it proved relatively easy to trace most (98 3%) of the obstetric and neonatal records during the three years. We also considered babies who were referred prenatally, and the only criterion for refusal was unavailability of an intensive care cot for neonates at the centre. As this was not a randomised study, we adjusted for confounding variables in comparing outcome in the groups.
Of babies initially refused admission to the centre, most (78 6%) were subsequently accepted into other neonatal intensive care units within Northern Ireland. There was no significant difference in outcome for babies managed in these units compared with those managed in the centre. In many cases, however, there was a considerable delay before babies refused admission to the centre could be given intensive care, and their long term outcome remains uncertain. We have shown previously that the incidence of handicap is significantly higher in babies referred for intensive care after birth compared with those accepted prenatally."' A delay in starting intensive care may therefore be important. Those babies who did not receive intensive care and remained in special care baby units had a greater than threefold increase in their odds on dying. In addition, survivors from these hospitals could be expected to have a higher incidence of handicap than those sent for intensive care, although follow up studies are needed to confirm this.
There was some imbalance in the indications for prenatal referral, particularly in the number of cases of pre-eclampsia and rhesus isoimmunisation. This reflects clinical practice in that delivery of mothers with these conditions can often be delayed until an intensive care cot becomes available.
The number of babies who needed intensive care but were refused admission may be an underestimate as obstetricians and paediatricians at the hospitals that refer such babies may have known that intensive care cots were not available at the centre and therefore did not request transfer. Examination of mortality related to birth weight in individual hospitals might clarify this further.
Our study confirmed the benefits of neonatal intensive care and its particular value in improving the survival of babies of low birth weight. Short term survival seemed to be similar in smaller neonatal intensive care units and the regional perinatal centre, but we did not look at long term outcome and handicap. Further studies are needed to determine the influence of delay in starting intensive care on short term outcome and handicap. Clearly, in Northern Ireland, as in other parts of the United Kingdom,5 not enough neonatal intensive care cots are provided and the deficiency should be remedied as soon as possible.
Introduction
Many additives are used in drugs by the pharmaceutical industry for a variety of reasons, including improved identification and stability. Although adverse reactions to drugs have been reported and investigated for many years, adverse reactions to drug additives such as colourings and preservatives have been reported only over the past 30 years.' 4 Some of the colourings and preservatives that are added to drugs are also added to foods, and various adverse reactions have been attributed to them, although the validity of reports has been questioned.5 Colourings, however, have been reported to cause urticaria6-'0 and preservatives, such as sulphites, to cause asthma."-" There is little evidence that food or drug additives cause hyperactivity in children'4 despite popular perceptions and the results of several studies."-"l
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